- Dosing and Application | LATISSE® Professional
LATISSE ® (bimatoprost ophthalmic solution) 0 03% Important Information Indication LATISSE® (bimatoprost ophthalmic solution) 0 03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness
- About LATISSE
LATISSE ® (bimatoprost ophthalmic solution) 0 03% Important Information Indication LATISSE® (bimatoprost ophthalmic solution) 0 03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness
- Proper Application | LATISSE® Professional
LATISSE ® (bimatoprost ophthalmic solution) 0 03% Important Information Indication LATISSE® (bimatoprost ophthalmic solution) 0 03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness
- Patient Selection | LATISSE® Professional
LATISSE ® (bimatoprost ophthalmic solution) 0 03% Important Information Indication LATISSE® (bimatoprost ophthalmic solution) 0 03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness
- Primary End Point Data | LATISSE® Professional
In the LATISSE ® US phase 3 clinical study (N = 278), the primary efficacy end point was overall eyelash prominence, measured using the Global Eyelash Assessment (GEA) scale * This photonumeric rating scale ranges from 1 (minimal) to 4 (very marked) and corresponds to frontal and superior eyelash views 2-4
- HOME | LATISSE®
LATISSE ® is the first prescription product to treat inadequate lashes—it’s believed to prolong the active eyelash growth phase It’s clinically proven to deliver lashes that are fuller, longer, and darker at 16 weeks
- The first prescription treatment for inadequate or not . . . - latisse. com
LATISSE® (bimatoprost ophthalmic solution) 0 03% — the first FDA-approved treatment for inadequate or not enough lashes
|